Black communities across the United States experience significantly high rates of colorectal cancer —about 20% to 30% higher than their white counterparts. How to better understand and address these ...

Tennessee and Alabama billboards by ACS CAN urge Congress not to cut cancer research funding ahead of crucial federal votes.

It’s a relatively common type of cancer. That’s the one thing Janet Kukreja, MD, director of urologic oncology at the CU Cancer Center and UCHealth University of Colorado Hospital, wants people to ...

Every year the second Saturday of October marks World Hospice and Palliative Care Day (WHPCD). This year WHPCD will be on Saturday 11 October 2025. Each year the WHPCD campaign has a theme that is ...

Glucagon-like peptide-1 receptor agonist drugs (GLP-1s) such as Wegovy and Zepbound, have become game-changers in the world of weight-loss drugs. By reducing appetite and slowing down the rate at ...

American Cancer Society researchers say the increase in colorectal cancer screening among young adults is linked to rises in diagnosis.

Researchers at the National Institutes of Health (NIH) have shown for the first time that a type of human papillomavirus (HPV) commonly found on the skin can directly cause a form of skin cancer ...

Provides an opportunity to highlight the value of immunization across the lifespan. Activities focus on encouraging all people to protect their health by being vaccinated against infectious diseases.

President Donald Trump rode to reelection last fall on voter concerns about prices. But as his administration pares back federal rules and programs designed to protect patients from the high cost of ...

As the federal government and states move to cut about $1 trillion over the next decade from Medicaid, researchers estimate annual impacts by 2034 of hundreds of thousands of jobs lost and billions ...

Learn about the robotic surgery at CU that was used to remove and reconstruct Coach Prime’s bladder that had a “very high-risk” tumor.

Radiation plus immunotherapy induced a systemic anti-tumor immune response in lung cancers that do not typically respond to immunotherapy.